HIF1A‐AS2 predicts poor prognosis and regulates cell migration and invasion in triple‐negative breast cancer

Citations Over TimeTop 16% of 2019 papers

Abstract

The aberrant expression of hypoxia-inducible factor 1 alpha (HIF1A)-antisense RNA 2 (HIF1A-AS2) was found in various human cancers including breast cancer. The aim of this study was to present more evidence about the role HIF1A-AS2 on triple-negative breast cancer (TNBC). In our results, HIF1A-AS2 was also found to be upregulated in TNBC tissues compared with non-TNBC tissues or adjacent normal tissues. Besides, HIF1A-AS2 expression was also elevated in TNBC cell lines compared with the normal breast epithelial cell line. Moreover, high expression of HIF1A-AS2 was associated with lymph node metastasis, distant metastasis and unfavorable histological grade in TNBC patients. Survival analysis showed a TNBC patient with high HIF1A-AS2 expression had shorter overall survival than patients with low HIF1A-AS2 expression, and HIF1A-AS2 high expression acted as an independent poor prognostic factor for overall survival in TNBC patients. The cell migration and invasion assays suggested inhibition of HIF1A-AS2 obviously depressed TNBC cell migration and invasion. In conclusion, HIF1A-AS2 serves as a novel biomarker for predicting clinical progression and prognosis in TNBC.

Related Papers

• → Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer(2016)535 cited
• → Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy(2020)35 cited
• → Triple Negative Breast Cancer in an Appalachian Region(2021)1 cited
• → Triple Negative Breast Cancer: A Review(2009)1 cited
• A Contrastive Meta-analysis of Pathological Complete Response Rate in Neoadjuvant Chemotherapy between Triple-negative Breast Cancer and HER-2 Positive Breast Cancer(2014)